Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.

The gastrin receptor antagonist, CR2093, competed with 125I-gastrin-17 (5 x 10(-10) M) for binding to gastrin receptors on the rat pancreatic adenocarcinoma, AR42J (CR2093 concentration inducing 50% of 125I-gastrin-17 binding (IC50) was 8 x 10(-5) M), on the human gastric adenocarcinoma, MKN45 (IC50...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Watson, S. A., Crosbee, D. M., Morris, D. L., Robertson, J. F., Makovec, F., Rovati, L. C., Hardcastle, J. D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 1992
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977787/
https://ncbi.nlm.nih.gov/pubmed/1616859
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak